BARCLAYS PLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 129 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$252,000
+42.4%
172,345
+39.3%
0.00%
Q4 2016$177,000
-18.8%
123,710
-0.0%
0.00%
Q3 2016$218,000
+13.5%
123,722
+10.3%
0.00%
Q2 2016$192,000
+61.3%
112,200
-6.2%
0.00%
Q1 2016$119,000
-78.4%
119,620
-78.4%
0.00%
Q4 2015$552,000
-11.7%
552,627
-11.5%
0.00%
Q3 2015$625,000
-67.3%
624,335
+30.6%
0.00%
-100.0%
Q2 2015$1,911,000
+12.2%
477,960
+12.4%
0.00%
+50.0%
Q1 2015$1,703,000
-79.0%
425,341
-84.3%
0.00%
-75.0%
Q4 2014$8,106,000
+10.7%
2,701,324
+47.6%
0.01%
+14.3%
Q3 2014$7,323,000
-65.6%
1,830,556
-57.0%
0.01%
-68.2%
Q2 2014$21,276,000
-4.0%
4,254,545
+15.2%
0.02%
-12.0%
Q1 2014$22,169,000
+70.5%
3,694,687
+42.1%
0.02%
+78.6%
Q4 2013$13,003,000
+6.3%
2,600,052
+6.3%
0.01%
-6.7%
Q3 2013$12,233,000
-54.0%
2,446,428
-29.2%
0.02%
-54.5%
Q2 2013$26,597,0003,454,1650.03%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Camber Capital Management LP 9,750,000$18,623,0001.60%
DAFNA Capital Management LLC 381,600$729,0000.72%
SENZAR ASSET MANAGEMENT, LLC 1,766,991$3,374,953,0000.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,640,877$8,864,0000.34%
Lyons Wealth Management, LLC. 56,665$110,0000.14%
FEDERATED HERMES, INC. 5,648,920$10,789,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 33,909,459$64,767,0000.02%
Cubist Systematic Strategies, LLC 185,166$354,0000.02%
GAM Holding AG 523,164$997,0000.02%
STEVENS CAPITAL MANAGEMENT LP 191,236$365,0000.02%
View complete list of ARENA PHARMACEUTICALS INC shareholders